UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018589 |
|---|---|
| Receipt number | R000018657 |
| Scientific Title | Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study |
| Date of disclosure of the study information | 2015/08/10 |
| Last modified on | 2018/02/20 15:50:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study
Acronym
Phase-R Delirium Study
Scientific Title
Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study
Scientific Title:Acronym
Phase-R Delirium Study
Region
| Japan |
Condition
Condition
Malignancy
Classification by specialty
| Medicine in general | Psychosomatic Internal Medicine | Psychiatry |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety and efficacy of antipsychotic treatments for delirium in palliative care units and psychooncology consultation settings.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Delirium Rating Scale R-98 on day 3
Key secondary outcomes
NuDESC item 2-4
Communication Capacity Scale item 4
Agitation Distress Scale item 2
Adverse events
Drug-induced Extra-piramidal Symptom Scale(DIEPSS)
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Inpatients with advanced cancer aged 18 years or older who undergo antipsychotic treatments for hyper- or hypoactive delirium in palliative care units or psycho-oncology consultation settings
Key exclusion criteria
Patients with substance withdrawal delirium
Patient with postoperative delirium
Patients who undergo medical treatments intended to terminal sedation
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Asao Ogawa |
Organization
National Cancer Center East
Division name
Psycho-Oncology Division
Zip code
Address
6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan
TEL
04-7133-1111
asogawa@east.ncc.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Keisuke Ariyoshi |
Organization
The University of Tokyo, The Institute of Medical Science
Division name
Department of Palliative Medicine
Zip code
Address
4-6-1 Shiroganedai, Minato-ku, Tokyo, Japan
TEL
03-3443-8111
Homepage URL
http://www.jortc.jp/
k-ariyoshi@umin.ac.jp
Sponsor or person
Institute
The University of Tokyo, The Institute of Medical Science
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立がん研究センター東病院（千葉県）
国立がん研究センター中央病院（東京都）
名古屋市立大学大学院（愛知県）
岡山大学病院（岡山県）
千葉県がんセンター（千葉県）
市立札幌病院（北海道）
埼玉県立がんセンター（埼玉県）
東京大学医学部附属病院（東京都）
滋賀医科大学（滋賀県）
国立病院機構 近畿中央胸部疾患センター（大阪府）
慶應義塾大学病院（東京都）
聖隷三方原病院（静岡県）
小牧市民病院（岐阜県）
外旭川病院（秋田県）
川崎市立井田病院かわさき総合ケアセンター（神奈川県）
筑波メディカルセンター病院（茨城県）
ガラシア病院（大阪府）
聖路加国際病院（東京都）
栃木県立がんセンター（栃木県）
岡山済生会総合病院（岡山県）
六甲病院（兵庫県）
大阪市立総合医療センター（大阪府）
東北大学病院（宮城県）
島根大学医学部附属病院（島根県）
JCHO東京新宿メディカルセンター（東京都）
兵庫県立加古川医療センター（兵庫県）
永寿総合病院（東京都）
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 08 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 01 | Month | 09 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 08 | Month | 10 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Safety (Day7) and efficacy (Day3) of antipsychotic treatments for hyper- and hypoactive delirium will be evaluated
Management information
Registered date
| 2015 | Year | 08 | Month | 07 | Day |
Last modified on
| 2018 | Year | 02 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018657
